Haematinics are nutritional supplements required for the formation of blood cells, a process scientifically termed erythropoiesis. The primary nutrients classified under haematinics include iron, vitamin B12, and folic acid. Without adequate amounts of these substances, the bone marrow cannot produce healthy, mature erythrocytes, leading directly to various forms of anaemia. In clinical practice across Nigeria, nutritional anaemias remain a major public health challenge, particularly among pregnant women and young children.
Erythropoiesis relies on a steady supply of raw materials to support rapid cellular division and haemoglobin synthesis. Iron forms the core oxygen-binding moiety within haemoglobin molecules. Vitamin B12 and folic acid act as essential coenzymes in DNA synthesis, specifically facilitating purine and pyrimidine synthesis during cell replication. When any of these elements is missing, developing red blood cells stall in the bone marrow, resulting in ineffective erythropoiesis and the release of abnormally large or poorly hemoglobinized cells into the peripheral circulation.
Iron administration is the cornerstone treatment for iron deficiency anaemia. The body tightly regulates iron absorption in the duodenum and upper jejunum, absorbing only a fraction of what is ingested.
Oral iron is best absorbed on an empty stomach, but many patients take it with food to reduce nausea like epigastric pain and dark stools. Liquid oral iron preparations can stain the teeth, necessitating the use of a straw or dropper. Parenteral iron bypasses the gut entirely, making it useful for chronic kidney disease patients or those with severe malabsorption syndromes, but it carries a distinct risk of anaphylaxis.
Vitamin B12, or cobalamin, is essential for neurological function and DNA synthesis. Dietary B12 comes from animal products. Its absorption requires intrinsic factor, a glycoprotein secreted by the parietal cells of the gastric mucosa. Once bound to intrinsic factor, the complex travels to the terminal ileum where it is actively absorbed into the bloodstream.
Lack of intrinsic factor leads to pernicious anaemia, a specific type of vitamin B12 deficiency. Other causes include strict vegan diets, gastric bypass surgery, and ileal resection. Symptoms of B12 deficiency include megaloblastic anaemia alongside progressive neurological damage, such as peripheral neuropathy, numbness, and gait disturbances. Unlike folate deficiency, neurological symptoms do not occur in isolated folate deficiency and help differentiate the two conditions clinically. Replacement therapy often involves intramuscular injections of hydroxocobalamin or cyanocobalamin, especially when malabsorption is the root cause.
Folic acid, or vitamin B9, is a water-soluble vitamin vital for nucleic acid synthesis and amino acid metabolism. Rich dietary sources include dark green leafy vegetables, legumes, and fortified grains. Rapidly dividing tissues, such as bone marrow and the developing foetus, have the highest demand for folate. In pregnancy, inadequate folate intake dramatically increases the risk of neural tube defects in the newborn.
When folate is deficient, DNA replication slows down, causing erythroid precursors in the bone marrow to enlarge without dividing properly. This creates megaloblastic anaemia, characterized by large, fragile red blood cells known as macrocytes, alongside hypersegmented neutrophils. Management involves oral folic acid supplementation. Clinicians must always rule out a concurrent vitamin B12 deficiency before treating megaloblastic anaemia with high-dose folic acid alone, because correcting folate levels can temporarily improve the blood picture while allowing irreversible neurological damage from unrecognized B12 deficiency to progress unchecked.
Although haematinics are essential for treating nutritional deficiencies, they are not without side effects. Oral iron preparations frequently cause gastrointestinal disturbances, including nausea, epigastric discomfort, constipation, or diarrhoea. These symptoms often lead poor compliance among patients. Stool darkening is harmless but often frightens patients if they are not warned beforehand.
Acute iron poisoning, frequently seen in young children who accidentally ingest colourful iron tablets, is a medical emergency. It causes severe necrosis of the gastrointestinal mucosa, metabolic acidosis, shock, and cardiovascular collapse. The specific antidote for iron toxicity is deferoxamine, an iron-chelating agent that binds excess iron to form a water-soluble complex excreted in the urine. Parenteral iron therapies carry risks of hypersensitivity reactions ranging from minor rashes to life-threatening anaphylaxis, requiring emergency resuscitation equipment to be readily available during administration.
Comprehensive nursing care is vital for safe and effective haematinic therapy. The nurse must conduct baseline assessments, checking full blood count results, haemoglobin levels, and iron profiles before treatment starts. Dietary habits, socioeconomic factors, and history of gastrointestinal disorders must be thoroughly evaluated to identify the root cause of the deficiency.
Monitoring therapeutic response involves tracking the reticulocyte count, which typically rises within a week of starting effective iron or vitamin therapy, signaling active red blood cell production by the bone marrow. Haemoglobin levels should steadily increase over subsequent weeks. Nurses play a crucial role in patient education, explaining how to take oral medications, managing expected side effects like dark stools, and emphasizing the importance of completing the full course of treatment even after symptoms subside to rebuild bodily iron stores.